In obesity, persistent low-grade inflammation interferes with the hepcidin–ferroportin cycle, contributes to systemic iron maldistribution and impaired oxygen utilization in metabolically active tissues, and contributes to adipose tissue dysfunction and systemic metabolic dysfunction [33]. Here, HAMP is linked to obesity disorder.